WHO: 100 Countries To Enroll Patients For COVID-19 Vaccine Trials

The World Health Organization (WHO) has disclosed that about 100 countries have joined their proposed solidarity trial, adding that it expects them to take patients to designated hospitals, for that purpose.

The international clinical trial was launched by WHO and its partners for the purpose of finding an effective treatment for COVID-19.

“So far more than 100 countries have joined the solidarity trial to evaluate therapeutics for Covid-19 and 1200 patients have been randomized from the first five countries.

“This week, we expect that more than 600 hospitals, countries will be ready to start enrolling patients; the faster we recruit patients the faster we would get results, WHO Director General, Tedros Adhanom Ghebreyesus, added in Geneva on Monday.

According to a report on WHO’s website, the Solidarity trial would compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19.

The report also stated that by enrolling patients in multiple countries, the trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival.

WHO’s DG also stressed that the organization’s commitment was to science, solutions, solidarity and saving lives.

He also reemphasized that countries should not hurriedly lift restrictions at the moment.

“We have spoken previously recently about the factors countries must consider as they plan to start lifting the so called restrictions,” he said.